Accelerate Diagnostics Inc Beta
Quel est le Beta de Accelerate Diagnostics Inc?
Le Beta de Accelerate Diagnostics Inc est 0.32
Quelle est la définition de Beta?
BETA indique si une action est plus ou moins volatile que le marché dans son ensemble. Un bêta inférieur à 1 indique que l'action est moins volatile que le marché, tandis qu'un bêta supérieur à 1 indique que l'action est plus volatile. La volatilité est mesurée par la fluctuation du prix autour de la moyenne.
Beta is a measure of the risk arising from exposure to general market movements as opposed to idiosyncratic factors. The market portfolio of all investable assets has a beta of exactly 1. A beta below 1 can indicate either an investment with lower volatility than the market, or a volatile investment whose price movements are not highly correlated with the market. A beta greater than one generally means that the asset both is volatile and tends to move up and down with the market. Beta is important because it measures the risk of an investment that cannot be reduced by diversification. It does not measure the risk of an investment held on a stand-alone basis, but the amount of risk the investment adds to an already-diversified portfolio. In the capital asset pricing model, beta risk is the only kind of risk for which investors should receive an expected return higher than the risk-free rate of interest.
Beta des entreprises dans Health Care secteur sur NASDAQ par rapport à Accelerate Diagnostics Inc
Que fait Accelerate Diagnostics Inc?
accelerate diagnostics, inc. (nasdaq:axdx), is an in vitro diagnostics company focused on developing and commercializing innovative systems for the rapid identification and antimicrobial susceptibility testing of infectious pathogens. the company's revolutionary id/ast platform utilizes a proprietary process with both genomic and phenotypic detection technologies that significantly decreases time to result while achieving high sensitivity and specificity. in addition to the id/ast development pipeline, the company also owns and licenses its proprietary optichem™ surface coatings technology, which has numerous applications for binding in bio-analytical systems, such as microarrays.
Entreprises avec beta similaire à Accelerate Diagnostics Inc
- PSP Swiss Property AG a Beta de 0.32
- Imagi International a Beta de 0.32
- China Minsheng Banking a Beta de 0.32
- BOE Varitronix a Beta de 0.32
- China Overseas Land & Investment a Beta de 0.32
- Vogo SA a Beta de 0.32
- Accelerate Diagnostics Inc a Beta de 0.32
- Pimco California Municipal Income Fund II a Beta de 0.32
- Get Nice a Beta de 0.32
- Dierig AG a Beta de 0.32
- Sunlight Tech Hldg Ltd a Beta de 0.32
- Sunlight Technology a Beta de 0.32
- Whitehaven Coal a Beta de 0.32